Delfini Logo
Evidence- and Value-based Solutions for Health Care™
Clinical Improvement Consults, Content Development, Training & Seminars, Tools

Qualitative Systematic Review: Breast MRI In Diagnosis and Treatment of Cancer in Women at High Risk

The EBM Information Quest: Is it true? Is it useful? Is it usable?™

Delfini Co-founders: Michael E Stuart MD, President & Medical Director . Sheri Ann Strite, Managing Director & Principal

Quick Picks

Delfini: Dr. Michael E. Stuart & Sheri Ann Strite
Why Critical Appraisal Matters

Services
Services

Seminars
Seminars

Delfini Group Publishing
Books

Contact Us
Updates & Contact Info

Tools
Free Online Tools

Tutorial
Free Online Tutorial

blog
Delfini Blog


EBM Dolphin
Delfini
Click
Evidence & Quality Improvement Commentaries

 

Follow & Share...

Just-in-time UpdatesFollow Delfini Group on Twitter

Like Us Like Us on Facebook  Find UsFind Us at LinkedIn

Washington State Medical Technology Assessment

"Hello Sheri and Mike, thanks for shouting out to the Washington State Health Technology Clinical Committee. Along with the help of organizations like Delfini providing us with superb evidence reviews, we are showing a way that the US should follow, in my opinion. I appreciate your linking your contacts to our work. Best Wishes, Brian"

Brian R. Budenholzer, MD, FAAFP
Health Technology Clinical Committee Chair
Health Care Authority
State of Washington

Link to Delfini Washington State Health Care Technology work.

 

DelfiniGram™: GET ON OUR UPDATE LIST Contact Us

QUALITATIVE SYSTEMATIC REVIEW

Delfini conducted a qualitative systematic review which is being utilized by the Washington State’s Health Technology Assessment Program (HTA) and is available online: Delfini Qualitative Systematic Review: Breast MRI In Diagnosis and Treatment of Cancer in Women at High Risk. The aim of the review was to systematically review, critically appraise and analyze research evidence regarding the accuracy, efficacy, effectiveness and safety of MRI in the detection of breast cancer in women with a recent diagnosis of breast cancer and in women at high for breast cancer because of other risk factors such as a positive family history or known genetic mutations.

HTA is an innovative program that determines if health services used by state government are safe and effective and was showcased in the New England Journal of Medicine, where it was reported that the state estimated their first-year cost-savings to be 1.8 million dollars for a procedure that has good evidence that it is ineffective.

The primary goals of HTA are to make —

  • Health care safer by relying on scientific evidence and a committee of practicing clinicians
  • Coverage decisions of state agencies more consistent
  • State purchased health care more cost effective by paying for medical tools and procedures that are proven to work
  • Coverage decision process more open and inclusive by sharing information, holding public meetings, and publishing decision criteria and outcomes

HTA is leading the state effort to use evidence-based medicine to make health policy and coverage decisions that result in safer health care. The program acts as a resource to five participating agencies by sorting through a flood of information about selected medical technologies and producing reports that analyze the information and assess the quality of evidence. The program also provides transparency and consistency to industry stakeholders through publishing of criteria, inviting comments, holding open public meetings, and contracting for independent reports. Finally, coverage decisions are made by the Health Technology Clinical Committee (HTCC), an independent committee of health practitioners who review evidence on these medical devices, procedures, and test to ensure they are safe, work as promoted and provide value.

Read the Seattle Times news report on the Washington State Health Technology Assessment Program (HTA).

Read New England Journal of Medicine article referencing our work:
Franklin GM, Budenholzer BR. N Engl J Med. 2009 Oct 29;361(18):1722-5. Implementing evidence-based health policy in Washington State
. Department of Environmental and Occupational Health Sciences, University of Washington School of Public Health, Seattle, WA, USA. PMID: 19864671

........

Contact UsCONTACT DELFINI Delfini Group EBM DolphinDelfini Group EBM Dolphin

At MRI Breast

EBM Delfini boat

Read Our Blog...

Menu........
Use of our website implies agreement to our Notices. Citations for references available upon request.

Home
Best of Delfini
What's New
Blog

Seminars

Services
Delfini Group Publishing
Resources
Sample Projects
Notices
About Us & Our Work
Testimonials
Other
Site Search

Contact Info/Updates

........

Quick Navigator to Selected Resources

.......................


Return to Top

© 2002-2017 Delfini Group, LLC. All Rights Reserved Worldwide.
Use of this website implies your agreement to our Notices.

EBM Solutions for Evidence-based Health Care Quality